Otros idiomas Towa Pharmaceutical Co., Ltd.

Acciones

4553

JP3623150004

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2.806 ^JPY	+0,21 %		+0,39 %	+19,30 %

2023	Towa Pharmaceutical Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de marzo de 2023	CI
2022	Towa Pharmaceutical Co., Ltd. (TSE:4553) ha completado la adquisición de Sunsho Pharmaceutical Co., Ltd. a Carlyle Japan Partners III, un fondo gestionado por The Carlyle Group Inc. (NasdaqGS:CG).	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Towa Pharmaceutical Completes Payment for Director Stock Compensation	25/03
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	07/03
Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)	10/08/23
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)	10/08/23
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）	31/05/23
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)	15/05/23
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)	15/05/23
Towa Pharmaceutical : 2023年3月期決算短信〔日本基準〕（連結）	15/05/23
Towa Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	15/05/23
Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment	09/12/22
Towa Pharmaceutical Co., Ltd. completed the acquisition of Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG).	07/03/22
TOWA PHARMACEUTICAL : INTEGRATED REPORT 2021	21/12/21
Towa Pharmaceutical Co., Ltd. agreed to acquire Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG) for ¥47.7 billion.	17/12/21
Chugai - Towa Pharmaceutical Receives Approval for Authorized Generic Version of Chugai's Osteoporosis Agent Edirol	06/12/21
Protosera, Inc. announced that it expects to receive funding from Towa Pharmaceutical Co., Ltd.	24/03/21
Luye Pharma : Strikes Licensing Deal with Japan's Towa Pharma for Alzheimer's Disease Drug	18/02/21
Luye Pharma Switzerland AG and Towa Pharmaceutical Co., Ltd. Enters Strategic Collaboration to Develop and Commercialize Rivastigmine Multi-Day Transdermal Patch in Japan	18/02/21
Towa Pharmaceutical : Breckenridge Pharmaceutical, Inc. - Towa completes acquisition of Esteve's Generic Division	03/02/20
Towa Pharmaceutical Co., Ltd. completed the acquisition of Pensa Investments S.L. from Esteve Pharmaceuticals, S.A.	31/01/20
Innophys Co., Ltd. announced that it has received ¥3.53 billion in funding from a group of investors	25/12/19

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Towa Pharmaceutical Co., Ltd.

Acciones

4553

JP3623150004

Otros idiomas

Filtros